Skip to main content
Molecular Therapy. Methods & Clinical Development logoLink to Molecular Therapy. Methods & Clinical Development
. 2022 Mar 1;24:379. doi: 10.1016/j.omtm.2022.02.009

Long-Term Metabolic Correction of Phenylketonuria by AAV-Delivered Phenylalanine Amino Lyase

Rui Tao, Lin Xiao, Lifang Zhou, Zhaoyue Zheng, Jie Long, Lixing Zhou, Minghai Tang, Biao Dong ∗∗, Shaohua Yao
PMCID: PMC8891990  PMID: 35284591

Main text

(Molecular Therapy: Methods & Clinical Development, 19, 507–517; December 2020)

In the originally published version of this article, there was an unintended error in Figure. 3C. In particular, left panels of Figure. 3C (immunostaining images showing avPAL expression in PBS-injected female mice) were duplications of left panels Figure 2D (images showing avPAL expression in PBS-injected male mice). In order to correct these mistakes, the authors re-examined the raw data for immunostaining. With these raw data, the authors have now generated the correct Figure. 3C. Noteworthy, this correction does not affect the interpretation and the conclusions of the manuscript. The authors regret this error.

graphic file with name gr3.jpg

Figure 3. A Single Dose of AAV8-PAL Corrected Hyperphenylalaninemia in Female PKU Mice

Contributor Information

Biao Dong, Email: biaodong@scu.edu.cn.

Shaohua Yao, Email: shaohuayao@scu.edu.cn.


Articles from Molecular Therapy. Methods & Clinical Development are provided here courtesy of American Society of Gene & Cell Therapy

RESOURCES